Showing posts with label
cancers
.
Show all posts
Showing posts with label
cancers
.
Show all posts
Monday, September 23, 2024
IN treating Cancerous tumors, TransCode's technology is designed to target dysregulated microRNAs implicated in cancer progression, metastasis, and resistance to existing therapies.
›
Investor Report: TransCode Therapeutics Inc. (NASDAQ: RNAZ) Introduction TransCode Therapeutics Inc. is a clinical-stage biopharmaceutical...
Tuesday, July 2, 2024
"The rapid and complete resolution of aggressive MSS colorectal cancer tumors observed in this study is unprecedented in the field" says the author Dr. Kasi
›
On June 28th Agenus Inc . ("Agenus") (Nasdaq: $AGEN), announced results from an investigator-sponsored trial (IST) of botensili...
Sunday, May 12, 2024
Recursion Pharmaceuticals is at the forefront of AI-driven drug discovery!
›
Recursion Pharmaceuticals has caught the attention of major pharmaceutical companies due to its innovative approach to drug discovery. Mo...
Saturday, May 11, 2024
The Human body is highly "Adaptive" in fighting desease, and these two companies are developing technology right now to help that system fight Cancer!
›
Let’s compare Adaptive BioTechnologies and Agenus Inc . in terms of how they utilize the adaptive immune system to combat cancer: ...
›
Home
View web version
